Pyruvate kinase (PKM2), another known target of ATO, can modulate oncogenic anaerobic glycolysis, known as the Warburg effect, inducing further tumorigenesis and proliferation of cancer cells because PKM2 deletion can enhance oxidative phosphorylation [146]. The gene discussed is PKM; the disease is cancer.